SEDA PHARMA DEVELOPMENT SERVICES LTD.
BURY

Hellopages » Greater Manchester » Bury » BL9 8JE

Company number 09442533
Status Active
Incorporation Date 17 February 2015
Company Type Private Limited Company
Address 3 CASTLEBROOK CLOSE, UNSWORTH, BURY, LANCASHIRE, UNITED KINGDOM, BL9 8JE
Home Country United Kingdom
Nature of Business 72190 - Other research and experimental development on natural sciences and engineering
Phone, email, etc

Since the company registration five events have happened. The last three records are Confirmation statement made on 17 February 2017 with updates; Total exemption small company accounts made up to 31 March 2016; Annual return made up to 17 February 2016 with full list of shareholders Statement of capital on 2016-02-23 GBP 100 . The most likely internet sites of SEDA PHARMA DEVELOPMENT SERVICES LTD. are www.sedapharmadevelopmentservices.co.uk, and www.seda-pharma-development-services.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and eight months. Seda Pharma Development Services Ltd is a Private Limited Company. The company registration number is 09442533. Seda Pharma Development Services Ltd has been working since 17 February 2015. The present status of the company is Active. The registered address of Seda Pharma Development Services Ltd is 3 Castlebrook Close Unsworth Bury Lancashire United Kingdom Bl9 8je. . DE MATAS, Marcel is a Director of the company. DICKINSON, Paul Alfred is a Director of the company. The company operates in "Other research and experimental development on natural sciences and engineering".


Current Directors

Director
DE MATAS, Marcel
Appointed Date: 17 February 2015
52 years old

Director
DICKINSON, Paul Alfred
Appointed Date: 17 February 2015
57 years old

Persons With Significant Control

Mr Marcel De Matas
Notified on: 6 April 2016
52 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

Mr Paul Alfred Dickinson
Notified on: 6 April 2016
57 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

SEDA PHARMA DEVELOPMENT SERVICES LTD. Events

17 Feb 2017
Confirmation statement made on 17 February 2017 with updates
03 Nov 2016
Total exemption small company accounts made up to 31 March 2016
23 Feb 2016
Annual return made up to 17 February 2016 with full list of shareholders
Statement of capital on 2016-02-23
  • GBP 100

03 Jul 2015
Current accounting period extended from 28 February 2016 to 31 March 2016
17 Feb 2015
Incorporation
Statement of capital on 2015-02-17
  • GBP 100